- NEWS
- Update 31 March 2023
- Correction 31 March 2023
COVID-origins report sparks debate over major genome hub GISAID
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 616, 13-14 (2023)
doi: https://doi.org/10.1038/d41586-023-00901-9
Updates & Corrections
-
Update 31 March 2023: GISAID has now removed the additional restrictions that it had introduced for access to the China CDC data; the story has been changed to reflect that.
-
Correction 31 March 2023: An earlier version of this story said that GISAID had clarified its rules for access to the China CDC data after the Zenodo report was posted; in fact it added more restrictions.
References
Crits-Christoph, A. et al. Report at Zenodo https://doi.org/10.5281/zenodo.7754299 (2023).
Gao, G. et al. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-1370392/v1 (2022).